Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy  Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine.

Published byNicholas Ford Modified over 5 years ago

Similar presentations

Presentation on theme: "Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy  Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine."— Presentation transcript:

1 Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy 
Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine Rüedi, MD, Seraina von Moos, MD, Theodor Sonderegger, PhD, Pål Johansen, PhD, Thomas M. Kündig, MD  Journal of Allergy and Clinical Immunology  Volume 124, Issue 5, Pages (November 2009) DOI: /j.jaci Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 The patch consisted of a 3 × 5 cm polyethylene pouch that was filled with grass pollen extract in Vaseline. The side of the pouch that faced the skin was perforated. The pouch was held onto the skin by a self-adhesive tape. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Participant flow. Flowchart characterizing the study population. V4, visit 4; V5, visit 5. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Local eczema reactions. At visit 2, each of 6 symptoms (erythema, edema/induration/ papule formation, excoriation, weeping/exudation/scab formation, desquamation, lichenification) was recorded as none, mild, moderate, or severe, and a sum score (0-18 points) was calculated. Verum patients (open triangles) showed significantly more local reactions than placebo patients (filled triangles; Mann-Whitney exact test, P = .03). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 NPTs. Scores using the allergen dose 100,000 SQ-U are depicted. The box plots show the median; the 10th, 25th, 75th, and 90th percentiles; and outliers. White box plots represent the placebo group, and gray box plots represent the allergen-treated group. Statistically significant P values are indicated where values differ from baseline (∗P < .05; ∗∗P < .01; ∗∗∗P < .001). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Patient-recorded hay fever symptoms. Patients compared symptom severity during seasons 2006 and 2007 (posttreatment) with 2005 (pretreatment) and recorded scores between –10 (worst possible deterioration) and +10 (best possible improvement). Patients receiving verum (filled boxes) reported better improvement than placebo patients (open boxes; 2006, P = .02; 2007, P = .005). Box plots show median; 10th, 25th, 75th, and 90th percentiles; and outliers. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy  Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine."

Similar presentations

Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis  Anja P. Mose, MD, Charlotte G. Mortz, MD, PhD,

Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis  Anja P. Mose, MD, Charlotte G. Mortz, MD, PhD,
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,

High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,

Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation.

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation.
Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule  Carine Metz-Favre, MD, Birgit Linhart, PhD, Margarete Focke-Tejkl, PhD,

Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule  Carine Metz-Favre, MD, Birgit Linhart, PhD, Margarete Focke-Tejkl, PhD,
Evaluation of BCG administration as an adjuvant to specific immunotherapy in asthmatic children with mite allergy  Andrea Cohon, MD, L. Karla Arruda,

Evaluation of BCG administration as an adjuvant to specific immunotherapy in asthmatic children with mite allergy  Andrea Cohon, MD, L. Karla Arruda,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
Suzana Radulovic, MD, Mikila R. Jacobson, PhD, Stephen R

Suzana Radulovic, MD, Mikila R. Jacobson, PhD, Stephen R
Safety of allergen immunotherapy: A 10-year prospective study

Safety of allergen immunotherapy: A 10-year prospective study
Response to sublingual immunotherapy with grass pollen extract: Monotherapy versus combination in a multiallergen extract  Sheila M. Amar, MD, Ronald.

Response to sublingual immunotherapy with grass pollen extract: Monotherapy versus combination in a multiallergen extract  Sheila M. Amar, MD, Ronald.
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial  Laila Hellkvist, MD,

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial  Laila Hellkvist, MD,

Similar presentations

Ads by Google